# Propranolol and Von Hippel-Lindau Disease

> **NCT05424016** · NA · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 85 (estimated)

## Conditions studied

- Hemangioblastoma of CNS
- Von Hippel-Lindau Disease

## Interventions

- **DRUG:** Propranolol
- **OTHER:** follow-up

## Key facts

- **NCT ID:** NCT05424016
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-16
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2023-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05424016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05424016, "Propranolol and Von Hippel-Lindau Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05424016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*